12th Annual International Congress on Targeted Therapies in Cancer

The 12th Annual International Congress on Targeted Therapies in Cancer® is designed to provide participants with cutting-edge information on current and emerging targeted anticancer therapies, including the most current clinical data on those agents,their mechanism of action, and best practices for integrating targeted therapies into the care of patients with cancer. The congress will provide a unique opportunity for medical oncologists and researchers to learn from and interact with international leaders in clinical research and to obtain a preview of agents in development for the next generation of cancer therapy. Topics to be discussed in the fields of lung, breast, GI, GU, and hematologic malignancies include inhibitors of HER, ALK, and PI3K/mTOR, as well as antibody-drug conjugates and emerging immune-checkpoint inhibitors.